Patents by Inventor Peter Zygmunt

Peter Zygmunt has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
    Publication number: 20040209959
    Abstract: The present invention relates to new analgesic, antipyretic and/or anti-inflammatory compounds represented by the general formula X—Y, in which X is a benzyl group, a saturated or unsaturated cycloalkyl group (I,II) or a non-cyclic, straight or branched alkyl group (III,IV).
    Type: Application
    Filed: April 8, 2004
    Publication date: October 21, 2004
    Inventors: Edward Hogestatt, Peter Zygmunt
  • Anandamide and structurally related lipids as vanilloid receptor modulators
    Publication number: 20040204486
    Abstract: The invention discloses that anandamide is an endogenous ligand for vanilloid receptors, and especially the vanilloid receptor VR1. Other structurally related lipids, such as AM404, 1-arachidonylglycerol, and 2-arachidonylglycerol, are identified having vanilloid receptor activity as well. Methods of treating individuals suffering from, or at risk of suffering from, diseases and disorders associated with abnormal vanilloid receptor function are provided, as are methods of designing and identifying vanilloid receptor agonists and antagonists.
    Type: Application
    Filed: April 1, 2003
    Publication date: October 14, 2004
    Inventors: Edward Hogestatt, Peter Zygmunt
  • Anandamide and structurally related lipids as vanilloid receptor modulators
    Publication number: 20020019444
    Abstract: The invention discloses that anandamide is an endogenous ligand for vanilloid receptors, and especially the vanilloid receptor VR1. Other structurally related lipids, such as AM404, 1-arachidonylglycerol, and 2-arachidonylglycerol, are identified having vanilloid receptor activity as well. Methods of treating individuals suffering from, or at risk of suffering from, diseases and disorders associated with abnormal vanilloid receptor function are provided, as are methods of designing and identifying vanilloid receptor agonists and antagonists.
    Type: Application
    Filed: May 8, 2001
    Publication date: February 14, 2002
    Inventors: Edward Hogestatt, Peter Zygmunt